These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2466127)

  • 1. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells.
    Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW
    J Natl Cancer Inst; 1989 Apr; 81(7):502-12. PubMed ID: 2466127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons.
    Guadagni F; Schlom J; Greiner JW
    Int J Rad Appl Instrum B; 1991; 18(4):409-12. PubMed ID: 1907601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells.
    Greiner JW; Guadagni F; Goldstein D; Smalley RV; Borden EC; Simpson JF; Molinolo A; Schlom J
    J Clin Oncol; 1992 May; 10(5):735-46. PubMed ID: 1569446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.
    Tran R; Hand PH; Greiner JW; Pestka S; Schlom J
    J Interferon Res; 1988 Feb; 8(1):75-88. PubMed ID: 3130426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Mariani-Costantini R; Greiner JW; Casciani CU; Schlom J
    J Clin Oncol; 1996 Jul; 14(7):2031-42. PubMed ID: 8683233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression.
    Greiner JW; Tobi M; Fisher PB; Langer JA; Pestka S
    Int J Cancer; 1985 Aug; 36(2):159-66. PubMed ID: 3160671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
    Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer.
    Mahvi DM; Madsen JA; Witt PL; Sondel PM
    Cancer Immunol Immunother; 1995 May; 40(5):311-4. PubMed ID: 7600563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
    Greiner JW; Fisher PB; Pestka S; Schlom J
    Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
    Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
    Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferons.
    Sivinski CL; Lindner DJ; Borden EC; Tempero MA
    J Immunother Emphasis Tumor Immunol; 1995 Oct; 18(3):156-65. PubMed ID: 8770771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon.
    Kantor J; Tran R; Greiner J; Pestka S; Fisher PB; Shively JE; Schlom J
    Cancer Res; 1989 May; 49(10):2651-5. PubMed ID: 2496918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
    Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
    Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells.
    Ullmann CD; Schlom J; Greiner JW
    J Immunother (1991); 1992 Nov; 12(4):231-41. PubMed ID: 1477074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.
    Greiner JW; Guadagni F; Goldstein D; Borden EC; Ritts RE; Witt P; LoBuglio AF; Saleh MN; Schlom J
    Cancer Res; 1991 Aug; 51(16):4155-63. PubMed ID: 1907881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
    Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
    Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human leukocyte interferon induces alterations in the antigen phenotype of human breast carcinoma cells.
    Greiner JW
    Anticancer Res; 1986; 6(4):653-8. PubMed ID: 3752945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.